17
www.bioindustrypark.eu - [email protected] Fabrizio Conicella [email protected]

Bioindustry Park Silvano Fumero and bioPmed

Embed Size (px)

DESCRIPTION

Marseille MET3 Conference presentation. 2nd April 2012.

Citation preview

Page 1: Bioindustry Park Silvano Fumero and bioPmed

www.bioindustrypark.eu - [email protected]

Fabrizio Conicella – [email protected]

Page 2: Bioindustry Park Silvano Fumero and bioPmed

1. Bioindustry Park Silvano Fumero and

bioPmed

2. Bioprotech: overview

3. Bioindustry Park and Bioprotech

4. Lesson learned

Contents

Page 3: Bioindustry Park Silvano Fumero and bioPmed

Science park

specialised in health

care

22.000 sqm labs and

office spaces for

companies

Conference center

Consultancy in

biomanagement

Incubator

R&D service delivery

R&D shared facility

Cluster managing

company focused in

health care: bioPmed

www.bioindustrypark.eu

www.biopmed.eu

Bioindustry Park Silvano Fumero

Page 4: Bioindustry Park Silvano Fumero and bioPmed

The “traditional approach”

(One problem, one technology, one solution)

The “NEW” approach”

(Converging technologies)

- Up to 250 companies working specifically in

health care

- Over xx.000 companies working in ICT,

Mechatronics, New Materials, textiles, etc

The bioPmed “smart”approach…

80 bioPmed cluster CORE MEMBERS

share the approach of an Healthcare cluster aiming at

“Overlapping different technological knowledge to reach innovative solutions to

unmet medical needs and ensure a better future

Impact on Industry-research collaborations

Page 5: Bioindustry Park Silvano Fumero and bioPmed

The bioPmed pillars of action

www.biopmed.eu

And its supporting intitutions

Page 6: Bioindustry Park Silvano Fumero and bioPmed
Page 7: Bioindustry Park Silvano Fumero and bioPmed

The bioPmed community

BioCulture

80 core

member

Page 8: Bioindustry Park Silvano Fumero and bioPmed

Why to internationalize??? • Problems are global, Markets are global, finance is more and

more global, science is global, , optimizing health care costs is a global trend…......…..

• Big players are “global”: they are acting following a global strategy

• Small/medium players are willing to be global but…. – Lack of culture and skills

– Too focused on scientific development more than to company development

– Not enough resources

– Need for partnerships

• Critical mass in R&D and innovative companies become critical factors for territorial development

• Financial resources are scarce: single actors and single territories can’t afford the entire spectrum of investments of R&D to be competitive in every sector

• Lower transfer of public resources to R&D facilities

• Need to maximise positive impact of investments realised (job creation and sustainability)

• Local policies are interconnected (e.g. EU influence..)

Reg

ion

s

C

om

pan

ies&

R&

D

Page 9: Bioindustry Park Silvano Fumero and bioPmed

Why to cooperate in the mediterranean

area? • Advantages from the cooperative approach:

– Starting from local assets exploiting synergies between

territories

– Win-win activities: complementarity approach (value effective)

– Exploiting in a cooperative way the best components of a process also if they are located in a different territory

– Minimize “bad” competition

– Sustainability

– Minimize duplications of activities

It requires a cultural shift!!!!!

Page 10: Bioindustry Park Silvano Fumero and bioPmed

10

Project full title: Improve research capacities of the Centre of Biotechnology

of Sfax (Tunisia) in Bio-Processes for biotech applications, tying up with the

European Research Area

keywords: Biotech, bioprocesses, joint research, technology

transfer, ERA, regional impact, research policies

Duration (month): 30, from 1st November 2010

Project coordinator: CBS Sfax

Call: FP7-INCO-2010-6: Integrating Europe's neighbours into the ERA -WIDE

activity

BioProtech Project Overview

bioprotech.org

Page 11: Bioindustry Park Silvano Fumero and bioPmed

Project consortium partners

Participant No. Participant organisation name Short Name Country

1 (Coordinator) Centre of Biotechnology of Sfax CBS Tunisia

2 International Centre for Genetic

Engineering and Biotechnology ICGEB Italy

3 National Institute of Applied Sciences

of Toulouse INSA France

4 Steinbeis Research Center SFZ Germany

5 Bioindustry Park Silvano

Fumero/bioPMed BiPCa Italy

6 University of Claude Bernard Lyon UCBL France

Page 12: Bioindustry Park Silvano Fumero and bioPmed

Bioprotech project

Project management

Dissemination WP4

WP2

WP5

WP3

WP6

WP 1

Page 13: Bioindustry Park Silvano Fumero and bioPmed

Bioprotech goals The following objectives will be addressed by BioProtech:

Improvement of the technological background and

research skills

Build up the knowledge base for commercialisation of

research results

Build up knowledge about European research funding

instruments

Increase the visibility of CBS on a local and European

level

Improvement of the future biotechnology development

at CBS, tying up with the European Research Area

Page 14: Bioindustry Park Silvano Fumero and bioPmed

TT support approach

Global trends

analysis

Local ecosystem

action/clustering

action

CBS situation

analysis

General

Need analisys/matching

with CBS analisys

TT/networking

guidelines Training

planning

Local situation

Report

D2.1

D2.2 D2.3

D2.5

Local situation

implementation

Task 2.1 Task 2.1

Task 2.2

Task 2.3

Map existing technology transfer

activities

Training, coaching

and awareness to

commercialisation of

research results

Build up local customer

and

supporter/collaborator

network

D2.4 Training

material

Page 15: Bioindustry Park Silvano Fumero and bioPmed

• Human resources are a key factor

• General training on TT is not perceived as useful:

specific/need focused training is well accepted/requested

• Avoid fire and forget activities: coaching and follow-up

caractherised by a specialistc/sectorial focus

• Community bulding approach as tool to growth, also

internationally

• Usually science is not a problem…exploitation at local

leve is a problem..

• Identify direct positive impact on the local system as a

driver

• It takes time…………

Lesson learned..up to now

Page 16: Bioindustry Park Silvano Fumero and bioPmed

Example of support • Start-up: Production of antigens, antibodies and

diagnosis kit developement (2008)

• Specific critical analisys of business idea (2010)

• Identification of scientifc assets/market assets/USP and

strategic advice (2010)

• Coaching in drafting business plan toghether with a

Tunisian consultants (2010)

• Support in developing a presentation for an elevator

pitch (US based investors) (2011). Identified as selected

project for a business trip in US for identification of

investors and analisys of market opportunities

BIOtechRDP

Page 17: Bioindustry Park Silvano Fumero and bioPmed

bioPmed @ Bioindustry Park Silvano Fumero S.p.A.

Via Ribes, 5 10010 Colleretto Giacosa (TO) Italy Tel. +39-0125-561311 Fax +39-0125-538350 [email protected] www.biopmed.eu www.bioindustrypark.eu

Is the team that wins not

the single player…